Management

<body topmargin=0 leftmargin=0 marginheight=0 marginwidth=0> <table cellpadding=0 cellspacing=0 border=0 height="100%"><tr> <td valign="top" width=210 BGCOLOR="#CC9922" TEXT="#080000" bgproperties="fixed" background="045d2962dakdei.png"> <div> <B><IMG SRC="09eb4b40.jpg" border=0 width="180" height="180" ALIGN="BOTTOM" HSPACE="0" VSPACE="0"></B></div> <bR> <div> <A HREF="id17.htm" TARGET="_top" TITLE="About WP"><I><B>About WP</B></I></A></div> <div> <A HREF="id18.htm" TARGET="_top" TITLE="Product Development"><I><B>Product Development</B></I></A></div> <div> <I><B>Management</B></I></div> <div> <A HREF="id20.htm" TARGET="_top" TITLE="Board of Advisors"><I><B>Board of Advisors</B></I></A></div> <div> <A HREF="id21.htm" TARGET="_top" TITLE="Contact Us"><I><B>Contact Us</B></I></A></div> <bR> </td> <td valign="top" width="100%" BGCOLOR="#FFFFFF" TEXT="#080000"> <div> <FONT SIZE="5" COLOR="#CC6600" FACE="Verdana" ><B>Wilmington Pharma</B></FONT><FONT SIZE="1" COLOR="#CC6600" FACE="Verdana" >     |   </FONT> <A HREF="index.htm" TARGET="_top" TITLE="Wilmington Pharma"> home</A></div> <bR> <div> Management</div> <div> <IMG SRC="0afad7d0.jpg" border=0 width="173" height="125" ALIGN="LEFT" HSPACE="8" VSPACE="0">W<FONT SIZE="2" COLOR="#555555" FACE="Verdana" >ilmington Pharmaceuticals is organized to focus the talents of the core management team on creating valuable new medicines while avoiding the large development and support staff of traditional pharmaceutical companies</FONT></div> <div> Overlaying telecommuting with carefully designed management practices, the core team can efficiently apply their time and talents to the <B>selection</B>, <B>development</B> and <B>licensing</B> of enhanced medicines at significantly lower scientific, regulatory, and financial risk than experienced by the pharmaceutical industry in general.  The <B>core management positions</B> for Wilmington Pharmaceuticals are:</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Chief Executive Officer - Eugene T. Haley:</B>  Mr. Haley has 30 years of experience in building customer focused organizations to identify and solve marketplace needs.  As the founder of Wilmington Pharmaceuticals, Mr. Haley is realizing his vision of identifying and delivering pharmaceutical product improvements to significantly improve patients' healthcare experiences.  The key focus of the company is to carefully listen to physicians and patients about their formulation and dosing needs, and then deliver cost effective solutions.</div> <div> His business career includes four years with a major contract drug development supplier, where he led the business development efforts as well as the international operations.  His responsibilities there also included the role of Chief Financial Officer.</div> <div> Prior to working at the drug development company, he spent 22 years with Eastman Kodak, where he and his team built a division to over $1 billion in sales and a commanding market share.</div> <div> The consistent theme of listening carefully to the needs of the marketplace and then building innovative solutions has characterized Mr. Haley's career.  Wilmington Pharmaceuticals is the complete expression of that business ideal in the pharmaceutical sector.</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Chief Operating Officer - David Johnston, Ph.D. </B> has 25 years experience in the pharmaceutical industry, with extensive knowledge of drug product development, regulatory approval management and technology transfer. He has developed and brought to market products covering all routine dosage forms for use in a broad range of therapeutic indications, including anti-infectives, cardiovascular/cardiopulmonary, diagnostic imaging agents, hormonal/steroid products, and oncology agents.  </div> <div> Dr. Johnston has been responsible for strategic management of multiple locations on a national and international scale with a focus on the timely and consistent delivery of both technical and financial results.  He served as Executive Vice President and COO of aaiPharma, Executive Vice President Drug Development and Chief Scientific Officer of Oread, in positions of increasing responsibility at Sanofi and at Sterling Winthrop and as a Research Fellow at the Max Planck Institute for Medicinal Research, Heidelberg, West Germany.  </div> <div> David has a B.S., Chemistry (1st class Honors), University of St. Andrews, St. Andrews, Scotland, 1972, and a Ph.D., Major Organic Chemistry, University of St. Andrews, St. Andrews, Scotland.</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Pre-Clinical Programs - Lawrence A. Pachla, Ph.D.:  Dr. Pachla </B>has 25 years of experience<B> </B>in the areas of drug development, robotics, electroanalytical chemistry, chromatography, pharmacokinetics, drug metabolism, the analytical biochemistry of proteinaceous drugs and information management.  </div> <div> Having managed drug development programs at McNeil Pharmaceuticals, Pfizer, Sanofi Synthelabo and Omnicare Pharmaceutics, Dr. Pachla is an acknowledged expert in CMC.  He has been a lecturer at Lawrence Technological University, and has published more than 50 papers.  </div> <div> Dr. Pachla is a member of the American Chemical Society, American Association of Pharmaceutical Sciences, and the American Association for the Advancement of Science.  He served on the Editorial Board of <I>Biomedical Chromatography</I>, the Advisory Boards of <I>Analytical Chemistry </I>and <I>Antimicrobial Agents and Chemotherapy </I>and was Assistant Program Chair for FACSS (1988-1990)</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Intellectual Property - Wyatt Pratt:  </B>Mr. Pratt is an attorney, licensed in Florida and New Jersey, and registered as a patent attorney with the United States Patent Office.  His experience includes corporate, private law practice and government employment.  His positions have included Senior Patent Counsel at aaiPharma Inc. and an examiner in the chemical arts at the United States Patent Office Mr. Pratt is a 1980 graduate of the United States Naval Academy (B.S. Chemistry) and received his juris doctor from Tulane University School of  Law.</div> <div> <B>Additional key advisors</B> critical to Wilmington Pharmaceuticals success are:</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Legal</B>: Wyrick, Robbins, Yates & Ponton, LLP, of Raleigh, NC.  Don Reynolds, Partner </div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Accounting and Finance</B>: Ernst & Young, of Raleigh, NC.  Horace Johnson, Managing Partner</div> <div> <B><IMG BORDER="0" SRC="Symb075c00b700c855555500.png" HEIGHT="13" WIDTH="24" ALIGN="bottom" HSPACE="0" VSPACE="0">Market Research:</B>  IMS Health is recognized as the global leader for pharmaceutical market intelligence.  They offer a full complement of information analysis and services to understand current pharmaceutical market behavior and project future outcomes..</div> <DIV ALIGN="LEFT"></DIV> <div> <TABLE BORDER="0" CELLPADDING="2" CELLSPACING="1" WIDTH="395" BORDERCOLORLIGHT="#C0C0C0" BORDERCOLORDARK="#808080" FRAME="BOX" RULES="ALL" HSPACE="0" VSPACE="0" > <tR> <tD VALIGN=TOP HEIGHT= 74 ><NOBR><div> <IMG SRC="0bdc8440.jpg" border=0 width="200" height="68" ALIGN="BOTTOM" HSPACE="0" VSPACE="0"></div> </NOBR></tD> <tD VALIGN=TOP><NOBR><bR> <div> <I><B>improving patient comfort</B></I></div> <div> <I><B>and compliance with</B></I></div> <div> <I><B>prescribed pharmaceuticals</B></I></div> </NOBR></tD> </tR> </TABLE></div> <bR> <bR> </td> </tr></table></body>